VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MRNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MRNAModerna, Inc.
$69.70$27.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMRNAQuarterly Financials

Moderna, Inc. (MRNA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Moderna, Inc. (MRNA) quarterly income statement — complete revenue, gross profit & net income history

MRNA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue389M678M1.02B142M107M956M1.85B221M167M2.81B1.83B344M1.84B5.15B3.22B4.57B5.94B6.95B4.83B4.21B
Revenue Growth %263.55%-29.08%-45.23%-35.75%-35.93%-66.01%1.31%-35.76%-90.91%-45.37%-43.14%-92.47%-69.06%-25.9%-33.32%8.33%240.79%1117.53%2958.07%6252.58%
Cost of Goods Sold955M452M1.01B119M90M739M514M115M96M929M2.24B731M792M1.92B1.1B1.38B1.02B952M722M750M
COGS % of Revenue245.5%66.67%99.21%83.8%84.11%77.3%27.71%52.04%57.48%33.03%122.39%212.5%43.09%37.25%34.16%30.25%17.12%13.7%14.95%17.79%
Gross Profit-566M226M8M23M17M217M1.34B106M71M1.88B-410M-387M1.05B3.23B2.12B3.19B4.92B6B4.11B3.46B
Gross Margin %-145.5%33.33%0.79%16.2%15.89%22.7%72.29%47.96%42.52%66.97%-22.39%-112.5%56.91%62.75%65.84%69.75%82.88%86.3%85.05%82.21%
Gross Profit Growth %-3429.41%4.15%-99.4%-78.3%-76.06%-88.48%427.07%127.39%-93.21%-41.69%-119.34%-112.15%-78.75%-46.12%-48.38%-8.08%217.61%980.33%2648.81%5797.77%
Operating Expenses822M1.08B268M930M1.07B1.46B1.41B1.47B1.34B1.88B1.6B1.48B1.41B1.65B954M738M696M587M549M403M
OpEx % of Revenue211.31%159.73%26.38%654.93%997.2%153.03%76.06%664.71%800.6%66.76%87.49%430.23%76.82%32.06%29.63%16.16%11.72%8.45%11.37%9.56%
Selling, General & Admin173M308M268M230M212M351M281M268M274M470M442M332M305M375M278M211M268M201M168M121M
SG&A % of Revenue44.47%45.43%26.38%161.97%198.13%36.72%15.15%121.27%164.07%16.71%24.14%96.51%16.59%7.28%8.63%4.62%4.51%2.89%3.48%2.87%
Research & Development649M775M801M700M856M1.12B1.14B1.22B1.03B1.41B1.16B1.15B1.13B1.21B820M710M554M648M521M421M
R&D % of Revenue166.84%114.31%78.84%492.96%800%117.36%61.29%552.49%614.97%49.98%63.35%333.72%61.53%23.52%25.47%15.55%9.33%9.33%10.79%9.99%
Other Operating Expenses00-1000K0-1000K-1000K-1000K-1000K1000K1000K00-1000K1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-1.39B-857M-260M-907M-1.05B-1.25B-70M-1.36B-1.27B6M-2.01B-1.87B-366M1.58B1.17B2.45B4.23B5.41B3.56B3.06B
Operating Margin %-356.81%-126.4%-25.59%-638.73%-981.31%-130.33%-3.77%-616.74%-758.08%0.21%-109.89%-542.73%-19.91%30.69%36.21%53.59%71.16%77.85%73.68%72.65%
Operating Income Growth %-32.19%31.22%-271.43%33.46%17.06%-20866.67%96.52%27%-245.9%-99.62%-272.56%-176.3%-108.66%-70.79%-67.23%-20.08%233.89%2067%1613.29%2607.23%
EBITDA-1.39B-790M-208M-850M-1.01B-1.19B-18M-1.32B-1.23B208M-1.76B-1.78B-288M1.66B1.28B2.52B4.31B5.49B3.63B3.13B
EBITDA Margin %-356.81%-116.52%-20.47%-598.59%-944.86%-124.06%-0.97%-598.19%-736.53%7.39%-96.29%-516.57%-15.67%32.24%39.72%55.26%72.49%78.98%75.13%74.28%
EBITDA Growth %-37.29%33.39%-1055.56%35.7%17.8%-670.19%98.98%25.61%-327.08%-87.47%-237.84%-170.43%-106.69%-69.75%-64.75%-19.42%236.14%2152.88%1700.94%2833.76%
D&A (Non-Cash Add-back)067M52M57M39M60M52M41M36M202M249M90M78M80M113M76M79M78M70M69M
EBIT0-799M-187M-817M-963M-1.18B27M-1.27B-1.16B76M-1.95B-1.74B-296M1.67B1.23B2.48B4.24B5.42B3.56B3.07B
Net Interest Income070M73M80M89M85M97M105M114M97M95M91M100M77M50M35M9M1M0-2M
Interest Income72M70M73M81M90M91M103M111M120M103M105M104M109M87M58M40M15M7M4M3M
Interest Expense0001M1M6M6M6M6M6M10M13M9M10M8M5M6M6M4M5M
Other Income/Expense54M58M73M89M86M62M91M84M101M64M54M118M61M75M51M27M2M0-6M1M
Pretax Income-1.33B-799M-187M-818M-964M-1.18B21M-1.28B-1.17B70M-1.96B-1.75B-305M1.66B1.22B2.47B4.23B5.41B3.55B3.06B
Pretax Margin %-342.93%-117.85%-18.41%-576.06%-900.93%-123.85%1.13%-578.73%-697.6%2.49%-106.94%-508.43%-16.59%32.14%37.8%54.18%71.2%77.85%73.56%72.67%
Income Tax9M27M13M7M7M-64M8M010M-147M1.67B-369M-384M190M174M277M572M542M219M283M
Effective Tax Rate %-0.67%-3.38%-6.95%-0.86%-0.73%5.41%38.1%0%-0.86%-210%-85.39%21.1%125.9%11.48%14.3%11.2%13.53%10.02%6.17%9.24%
Net Income-1.34B-826M-200M-825M-971M-1.12B13M-1.28B-1.18B217M-3.63B-1.38B79M1.47B1.04B2.2B3.66B4.87B3.33B2.78B
Net Margin %-345.24%-121.83%-19.68%-580.99%-907.48%-117.15%0.7%-578.73%-703.59%7.71%-198.25%-401.16%4.3%28.45%32.39%48.12%61.57%70.05%69.02%65.95%
Net Income Growth %-38.31%26.25%-1638.46%35.5%17.36%-616.13%100.36%7.32%-1587.34%-85.19%-448.03%-162.81%-97.84%-69.91%-68.71%-20.97%199.51%1886.52%1526.58%2481.91%
Net Income (Continuing)-1.34B-826M-200M-825M-971M-1.12B13M-1.28B-1.18B217M-3.63B-1.38B79M1.47B1.04B2.2B3.66B4.87B3.33B2.78B
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.55-9.53-3.620.203.622.535.248.5811.297.706.46
EPS Growth %-34.92%27.49%-1664.42%36.04%18.18%-629.09%100.34%8.01%-1640%-84.81%-476.68%-169.08%-97.67%-67.94%-67.14%-18.89%202.11%1736.23%1405.08%2183.87%
EPS (Basic)-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.57-9.53-3.620.203.812.675.559.0912.038.276.93
Diluted Shares Outstanding395M392M390M388M386M385M399M384M382M395M381M381M405M405M412M419M426M431M434M431M
Basic Shares Outstanding395M392M390M388M386M385M385M384M382M381M381M381M386M385M390M396M402M405M404M402M
Dividend Payout Ratio--------------------